Clinical trials
Observational Inflammation trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 5 |
| 2025 | 5 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Recruiting | 10 |
| Not yet recruiting | 4 |
| Unknown status | 4 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 8 |
| Centre Hospitalier Régional d'Orléans | 3 |
| University Hospital, Montpellier | 3 |
| Central Hospital, Nancy, France | 2 |
| Institut National de la Santé Et de la Recherche Médicale, France | 2 |
| University Hospital, Bordeaux | 2 |
| University Hospital, Clermont-Ferrand | 2 |
| University Hospital, Grenoble | 2 |
| University Hospital, Lille | 2 |
| University Hospital, Strasbourg, France | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammation | 43 |
| Atherosclerosis | 2 |
| Cachexia | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Diabetes Mellitus | 2 |
| Major Depressive Disorder | 2 |
| Multiple Sclerosis | 2 |
| Obesity | 2 |
| Pulmonary Disease, Chronic Obstructive | 2 |
| Sepsis | 2 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.